Becton, Dickinson and Company (BDX)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 231.55 |
| Open | 231.84 |
| Bid | 0.00 x 1100 |
| Ask | 235.43 x 1100 |
| Day's range | 231.84 - 234.50 |
| 52-week range | 229.40 - 287.32 |
| Volume | |
| Avg. volume | 1,339,604 |
| Market cap | 67.441B |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | 53.42 |
| EPS (TTM) | 4.37 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 3.80 (1.63%) |
| Ex-dividend date | 07 Mar 2024 |
| 1y target est | 275.42 |
PR NewswireBD to Present at Bank of America Securities Health Care Conference 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.
ZacksSustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
ZacksUnveiling Becton Dickinson (BDX) Q2 Outlook: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
© 2024 Yahoo. All rights reserved.